Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors

Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors

US Patent 7528153 · Granted May 5, 2009

Estimated economic value: $48,381,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

N-(5-((aryl or heteroaryl)methyloxy)pentyl)-substituted iminosugars as inhibitor2020
N-(5-((aryl or heteroaryl)methyloxy)pentyl)-substituted iminosugars as inhibitor2019
Activity based probes (ABPs) interacting with glycosidases2015
Treatment of cystic fibrosis2013
Use of a deoxynojirimycin derivative or a pharmaceutically salt thereof2010
Means and methods for detecting endoglycosidase activity2009
Human chitinase, its recombinant production, its use for decomposing chitin, its2005
Human chitinase, its recombinant production, its use for decomposing chitin, its2001
Deoxynojirimycin derivatives and their uses as glucosylceramidase inhibitors2001
Human chitinase, its recombinant production, its use for decomposing chitin, its2000
Human chitinase, its recombinant production, its use for decomposing chitin, its1999